Characteristic mTOR activity in Hodgkin-lymphomas offers a potential therapeutic target in high risk disease -- a combined tissue microarray, in vitro and in vivo study
Lymphoma Overview Timothy S. Fenske, MD April 5 th, 2014 Welcome!
Lymphoma Overview
